Cartalax 20mg Research Peptide

$185.00

10 VIALS / KIT

What is Cartalax?

Cartalax (AED; Ala-Glu-Asp) is an investigational short-peptide research material studied in laboratory models involving cartilage-cell differentiation, extracellular-matrix markers, and short-peptide regulation of gene expression. The available evidence is predominantly preclinical. For laboratory research use only.

In Stock

Cartalax 20mg Research Peptide quantity

Add to cart

Warehouse 🇨🇳 China Warehouse

• International Express $45.00 · 8–14 days

Warehouse order experiences — China Warehouse

These are order-level reviews from the same warehouse, not ratings of this individual product.

— 0 verified order reviews

No published order reviews yet.

View China Warehouse reviews

How Cartalax Works

Cartalax is a synthetic tripeptide with the sequence Ala-Glu-Asp (AED). Laboratory studies have examined AED in cell models involving chondrogenic differentiation and the expression of cartilage-associated markers such as SOX9, aggrecan, type II collagen, and COMP.

Reviews of short-peptide research also discuss peptide-DNA interaction and gene-expression regulation as proposed mechanisms for AED-class peptides. These observations are model-dependent, and no single validated receptor or established clinical mechanism has been confirmed for Cartalax.

Storage

Cartalax is supplied as a lyophilized powder. Unopened vials can be stored for up to 2 years at 2-8°C when kept sealed, dry, and protected from light. Avoid excessive heat, moisture, and repeated temperature changes.

After reconstitution with bacteriostatic water, store at 2-8°C, protected from light, and use within 30 days. Label the vial with the reconstitution date. Use sterile handling, mix gently rather than shaking, avoid repeated freeze-thaw cycles, and do not use material showing persistent particles, unexpected cloudiness, or discoloration.

FAQ

Why does the vial look empty or contain only a small amount of powder?

Twenty milligrams of lyophilized material can form a thin cake, film, or light residue on the vial wall or base. Let the vial stand upright and inspect it under good lighting. Appearance alone does not confirm the labeled mass; consult the lot-specific COA when quantitative confirmation is required.

What should I do if the powder is stuck to the side of the vial?

Keep the vial upright and allow it to reach room temperature before opening. Add the selected laboratory solvent slowly down the inside wall so it contacts the material gradually.

How should Cartalax be mixed after reconstitution?

Gently swirl or roll the vial. Do not shake vigorously. If bubbles form, allow the vial to rest refrigerated until the solution settles.

What if particles or cloudiness remain after mixing?

Confirm the solvent, volume, and preparation method, then allow the vial to rest at 2-8°C and inspect it again. If particles, cloudiness, or discoloration persist, quarantine the vial and contact support with photographs, the lot number, solvent, volume, and preparation date.

How can contamination risk be reduced after reconstitution?

Use sterile technique, disinfect the stopper before each access, avoid touching sterile surfaces, and return the vial promptly to refrigerated storage. Discard the solution after 30 days or sooner if contamination is suspected.

How can I distinguish standalone Cartalax from a Cartalax blend?

This product contains Cartalax 20 mg per vial and 10 vials per kit. Check the product name, specification, SKU, and lot-specific COA. A multi-component blend is a different product and should not be treated as analytically interchangeable.